Genus PLC
14 June 2006
For Immediate Release 14 June 2006
Genus plc
Disposal of SyAqua Brazil
In line with the strategy stated in the Interim Results announcement dated 7
June 2006 to divest the SyAqua Shrimp business, Genus plc ('Genus') the world's
leading animal genetics company, is pleased to announce the disposal of SyAqua
Brazil to an MBO-led team for a consideration of US $6.0m (£3.25m) in cash,
which approximates net asset value.
For the ten months ended 30 April 2006, SyAqua Brazil generated turnover of
£2.1m and an operating profit of £0.3m before research and development expense.
Commenting on the disposal Richard Wood, Chief Executive, said 'We have moved
swiftly to implement our strategy for disposal. With Brazil now sold, we are
considering offers for the Mexican and Thai shrimp businesses.'
FOR FURTHER INFORMATION
Genus plc
Richard Wood, Chief Executive Tel: 01256 345971
David Timmins, Group Finance Director Tel: 01256 345977
Buchanan Communications
Charles Ryland / Suzanne Brocks Tel: 020 7466 5000
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.